Wakefit Innovations grants 4.57 lakh ESOPs at Re. 1
Wakefit Innovations granted 4,57,611 ESOPs at Re. 1 per option under its 2019 plan, approved by the NRC on July 13, 2026. Options vest after 12 months and must be exercised within one year of vesting, complying with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Wakefit Innovations has granted 4,57,611 Employee Stock Options (ESOPs) to eligible employees under its Wakefit Employee Stock Option Plan - 2019. The grant, approved by the Nomination and Remuneration Committee (NRC) on July 13, 2026, aims to incentivize employees through equity ownership in the company. The options are priced at Re. 1 per share and will convert into equity shares of the same face value upon exercise.
The allocation of these options is in compliance with the Securities and Exchange Board of India (SEBI) (Share Based Employee Benefits & Sweat Equity) Regulations, 2021. The company confirmed that the scheme adheres to the regulatory framework, ensuring that the grant process meets all necessary disclosure and compliance standards mandated by the market regulator.
Vesting and Exercise Details
The granted options come with specific vesting and exercise timelines designed to align employee interests with long-term company performance. According to the disclosure, the options will vest after a minimum period of 12 months from the Grant Date and not later than 5 years. The actual vesting will be determined based on time and/or performance criteria as outlined in the Letter of Grant, subject to the employee's continued employment.
Once vested, the options can be exercised by the employees. All vested options must be exercised within a maximum period of 1 year from the date of vesting. The company noted that vesting timelines may be extended for unauthorized or non-statutory leaves as per the provisions of the ESOP Plan.
Key Terms of the Grant
The detailed terms of the ESOP grant were disclosed in an annexure to the regulatory filing. The table below summarizes the significant particulars of the options granted:
| Particulars | Details |
|---|---|
| Total Options Granted | 4,57,611 |
| Shares Covered | 4,57,611 equity shares |
| Face Value | Re. 1 |
| Exercise Price | Re. 1 per Option |
| Vesting Period | Minimum 12 months; maximum 5 years |
| Exercise Window | Within 1 year from vesting date |
The company stated that no options have been exercised, lapsed, or varied as of this disclosure, as the announcement pertains strictly to the initial grant. The information regarding the grant has been made available on the company's official investor relations website for shareholder reference.
Historical Stock Returns for Wakefit Innovations
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.26% | -6.74% | +1.22% | -31.34% | -34.92% | -34.92% |
How will this ESOP grant impact Wakefit's employee retention and talent acquisition strategy in the competitive sleep solutions market?
What are the potential market implications of the low exercise price of Re. 1 per share on future equity dilution for existing shareholders?
Could this ESOP grant signal Wakefit's preparations for an IPO or a significant funding round in the near future?


































